Correlation Between YD More and Medivie Therapeutic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both YD More and Medivie Therapeutic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining YD More and Medivie Therapeutic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between YD More Investments and Medivie Therapeutic, you can compare the effects of market volatilities on YD More and Medivie Therapeutic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in YD More with a short position of Medivie Therapeutic. Check out your portfolio center. Please also check ongoing floating volatility patterns of YD More and Medivie Therapeutic.

Diversification Opportunities for YD More and Medivie Therapeutic

-0.9
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between MRIN and Medivie is -0.9. Overlapping area represents the amount of risk that can be diversified away by holding YD More Investments and Medivie Therapeutic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medivie Therapeutic and YD More is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on YD More Investments are associated (or correlated) with Medivie Therapeutic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medivie Therapeutic has no effect on the direction of YD More i.e., YD More and Medivie Therapeutic go up and down completely randomly.

Pair Corralation between YD More and Medivie Therapeutic

Assuming the 90 days trading horizon YD More is expected to generate 2.04 times less return on investment than Medivie Therapeutic. But when comparing it to its historical volatility, YD More Investments is 2.14 times less risky than Medivie Therapeutic. It trades about 0.14 of its potential returns per unit of risk. Medivie Therapeutic is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  3,550  in Medivie Therapeutic on September 29, 2024 and sell it today you would earn a total of  450.00  from holding Medivie Therapeutic or generate 12.68% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

YD More Investments  vs.  Medivie Therapeutic

 Performance 
       Timeline  
YD More Investments 

Risk-Adjusted Performance

27 of 100

 
Weak
 
Strong
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in YD More Investments are ranked lower than 27 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, YD More sustained solid returns over the last few months and may actually be approaching a breakup point.
Medivie Therapeutic 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medivie Therapeutic has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

YD More and Medivie Therapeutic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with YD More and Medivie Therapeutic

The main advantage of trading using opposite YD More and Medivie Therapeutic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if YD More position performs unexpectedly, Medivie Therapeutic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medivie Therapeutic will offset losses from the drop in Medivie Therapeutic's long position.
The idea behind YD More Investments and Medivie Therapeutic pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios